Efficacy and Safety of PEG-rhG-CSF Secondary Prophylaxis vs. Therapeutic Administration in Patients With Ovarian Cancer

NCT03858166 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

68

Enrollment

OTHER

Sponsor class

Stopped Sponsor Termination

Conditions

Adjuvant Chemotherapy
Ovarian Neoplasms
Ovarian Cancer

Interventions

DRUG: PEG-rhG-CSF

Sponsor

Shandong University